受强制性开放获取政策约束的文章 - Maryam Hamzeh-Mivehroud了解详情
无法在其他位置公开访问的文章：3 篇
Histamine H3 receptor ligands by hybrid virtual screening, docking, molecular dynamics simulations, and investigation of their biological effects
N Ghamari, O Zarei, D Reiner, S Dastmalchi, H Stark, ...
Chemical Biology & Drug Design 93 (5), 832-843, 2019
强制性开放获取政策： German Research Foundation
In silico and in vitro studies of two non‐imidazole multiple targeting agents at histamine H3 receptors and cholinesterase enzymes
N Ghamari, S Dastmalchi, O Zarei, JA Arias‐Montaño, D Reiner, ...
Chemical Biology & Drug Design 95 (2), 279-290, 2020
强制性开放获取政策： European Commission
Development of New Inhibitors of HDAC1–3 Enzymes Aided by In Silico Design Strategies
N Cheshmazar, S Hemmati, M Hamzeh-Mivehroud, B Sokouti, M Zessin, ...
Journal of Chemical Information and Modeling 62 (10), 2387-2397, 2022
强制性开放获取政策： German Research Foundation
可在其他位置公开访问的文章：2 篇
Ligand‐based Discovery of Novel Small Molecule Inhibitors of RON Receptor Tyrosine Kinase
O Zarei, N Faham, H Vankayalapati, SL Raeppel, AL Welm, ...
Molecular Informatics 41 (1), 2000181, 2022
强制性开放获取政策： US Department of Defense, US National Institutes of Health, Susan G. Komen
Guided rational design with scaffold hopping leading to novel histamine H3 receptor ligands
N Ghamari, SK Hargelan, A Zivkovic, L Leitzbach, S Dastmalchi, H Stark, ...
Bioorganic Chemistry 117, 105411, 2021
强制性开放获取政策： European Commission
出版信息和资助信息由计算机程序自动确定